- Dec. 11, 2018
-- EMJ Gastroenterology 7.1
is now available, presenting a full review of UEG Week 2018, this year held in the Austrian capital: Vienna.
This year's event was the biggest yet, with Prof Herbert Tilg, Chair of the UEG Scientific Committee, confirming it as "the most important forum to present gastrointestinal research." Detailing results from the UNIFI Phase III trial into ustekinumab as an induction therapy for moderate-to-
severely active ulcerative colitis, a comparison between laparoscopic ileocaecal resection and infliximab for the treatment of immunomodulator-
refractory Crohn's disease, and research from the USA into the risk factors for colorectal cancer in those aged 20–49 years, EMJ's extensive Congress Review details all of the headline news disseminated at the event.
As always, the latest edition of EMJ Gastroenterology
features an assortment of peer-reviewed articles sure to fascinate those working within the field, with topics ranging from the use of probiotics to prevent infantile colic to pathological considerations of colorectal polyps. Additionally, the eJournal contains key insights from members of the EMJ Gastroenterology
Editorial Board, alongside a selection of captivating abstract reviews taken from the array of presentations on offer at this year's UEG Week.
The EMJ team are certain this latest publication will provide a springboard for productive discussion and dissemination of the latest advances in digestive health, and hope the information presented inside will spark new developments within clinical practice. (https://www.emjreviews.com/gastroenterology/journal/emj-g...)